Fig. 2From: Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysisRisk of the first recurrence between days 7 and 90 in patients with adherence by supervision. The shaded areas represent 95% CIs. There were no patients with adherence by supervision between > 50– <90%.Back to article page